‘Zombie' biotech buyer Xoma to acquire Generation Bio [Yahoo! Finance]
Generation Bio Co. - Common stock (GBIO)
Company Research
Source: Yahoo! Finance
Xoma Royalty, which has recently built a business out of acquiring struggling biotechnology companies, has secured its latest target. In announcement late Monday, Xoma said it has agreed to pay about $4.29 per share to acquire Generation Bio, a gene therapy developer that's currently worth less than its cash holdings. The per-share acquisition price is lower than Generation's $5.39 closing price on Monday. But Generation's shareholders will also receive a so-called contingent value right making them eligible to receive additional payments. Among those possible payouts are a share of any cash on hand at closing, if that total exceeds $29 million; savings on a Generation office lease; a piece of future milestones from a licensing deal with Moderna; and the proceeds, if any, should Xoma sell a delivery technology Generation had been working on. Generation's board of directors unanimously approved the deal. Generation raised $200 million in an initial public offering in 2020, rid
Show less
Read more
Impact Snapshot
Event Time:
GBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GBIO alerts
High impacting Generation Bio Co. - Common stock news events
Weekly update
A roundup of the hottest topics
GBIO
News
- Generation Bio (NASDAQ:GBIO) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Generation Bio (NASDAQ:GBIO) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $5.50 price target on the stock, down previously from $7.00.MarketBeat
- NodThera Appoints Geoff McDonough, M.D., as Independent Board Member [Yahoo! Finance]Yahoo! Finance
- NodThera Appoints Geoff McDonough, M.D., as Independent Board MemberGlobeNewswire
- Generation Bio (NASDAQ:GBIO) was downgraded by analysts at Jefferies Financial Group Inc. to a "hold" rating.MarketBeat
GBIO
Earnings
- 11/5/25 - Beat
GBIO
Sec Filings
- 12/16/25 - Form SC
- 12/15/25 - Form SC14D9C
- 12/15/25 - Form 8-K
- GBIO's page on the SEC website